Pilon, D., Patel, C., Lafeuille, M., Zhdanava, M., Lin, D., Côté-Serhent, A., . . . Joshi, K. (2020). PMH17 ECONOMIC BURDEN OF MEDICAID BENEFICIARIES WITH SCHIZOPHRENIA NOT ADHERENT TO ANTIPSYCHOTICS AND WITH SCHIZOPHRENIA RELAPSES. Value in Health, 23, S203. https://doi.org/10.1016/j.jval.2020.04.638
Chicago Style (17th ed.) CitationPilon, D., C.A Patel, M.H Lafeuille, M. Zhdanava, D. Lin, A. Côté-Serhent, C. Rossi, P. Lefebvre, and K. Joshi. "PMH17 ECONOMIC BURDEN OF MEDICAID BENEFICIARIES WITH SCHIZOPHRENIA NOT ADHERENT TO ANTIPSYCHOTICS AND WITH SCHIZOPHRENIA RELAPSES." Value in Health 23 (2020): S203. https://doi.org/10.1016/j.jval.2020.04.638.
MLA (9th ed.) CitationPilon, D., et al. "PMH17 ECONOMIC BURDEN OF MEDICAID BENEFICIARIES WITH SCHIZOPHRENIA NOT ADHERENT TO ANTIPSYCHOTICS AND WITH SCHIZOPHRENIA RELAPSES." Value in Health, vol. 23, 2020, p. S203, https://doi.org/10.1016/j.jval.2020.04.638.